Paloma H. Giangrande
Affiliations: | Molecular & Cell Biology | University of Iowa, Iowa City, IA |
Area:
Molecular Biology, Cell Biology, OncologyGoogle:
"Paloma Giangrande"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Lei B, Liu LB, Stokes L, et al. (2023) Smooth muscle cell-targeted RNA ligand promotes accelerated reendothelialization in a swine peripheral injury model. Molecular Therapy. Nucleic Acids. 34: 102023 |
| Kolovskaya OS, Zyuzyukina AV, Dassie JP, et al. (2023) Monitoring of breast cancer progression via aptamer-based detection of circulating tumor cells in clinical blood samples. Frontiers in Molecular Biosciences. 10: 1184285 |
| Santana-Viera L, Dassie JP, Rosàs-Lapeña M, et al. (2023) Combination of protein and cell internalization SELEX identifies a potential RNA therapeutic and delivery platform to treat EphA2-expressing tumors. Molecular Therapy. Nucleic Acids. 32: 758-772 |
| Liu W, Iwamoto N, Marappan S, et al. (2023) Impact of stereopure chimeric backbone chemistries on the potency and durability of gene silencing by RNA interference. Nucleic Acids Research |
| Yazdani SK, Lei B, Cawthon CV, et al. (2022) Local intraluminal delivery of a smooth muscle-targeted RNA ligand inhibits neointima growth in a porcine model of peripheral vascular disease. Molecular Therapy. Nucleic Acids. 29: 577-583 |
| Shigdar S, Schrand B, Giangrande PH, et al. (2021) Aptamers: cutting edge of cancer therapies. Molecular Therapy : the Journal of the American Society of Gene Therapy |
| Catuogno S, Esposito CL, Giangrande PH. (2021) Stick-Based Methods for Aptamer-Mediated siRNA Targeted Delivery. Methods in Molecular Biology (Clifton, N.J.). 2282: 31-42 |
| Ptacek J, Zhang D, Qiu L, et al. (2020) Structural basis of prostate-specific membrane antigen recognition by the A9g RNA aptamer. Nucleic Acids Research |
| Almacellas-Rabaiget O, Monaco P, Huertas-Martinez J, et al. (2020) LOXL2 Promotes Oncogenic Progression in Alveolar Rhabdomyosarcoma Independently of its Catalytic Activity. Cancer Letters |
| Veeramani S, Blackwell SE, Thiel WH, et al. (2019) An RNA aptamer-based biomarker platform demonstrates high soluble CD25 occupancy by IL2 in the serum of follicular lymphoma patients. Cancer Immunology Research |